נורפרולק 0.025 מג Ισραήλ - Εβραϊκά - Ministry of Health

נורפרולק 0.025 מג

ferring pharmaceuticals ltd - quinagolide as hydrochloride - טבליה - quinagolide as hydrochloride 0.025 mg - quinagolide - quinagolide - second line treatment of hyperprolactinaemia (idiopathic or due to prolactin secreting micro- or macroadenoma) and its clinical manifestation (galactorrhoea, oligomenorrhea, infertility, reduced libido).

נורפרולק 0.05 מג Ισραήλ - Εβραϊκά - Ministry of Health

נורפרולק 0.05 מג

ferring pharmaceuticals ltd - quinagolide as hydrochloride - טבליה - quinagolide as hydrochloride 0.05 mg - quinagolide - quinagolide - second line treatment of hyperprolactinaemia (idiopathic or due to prolactin secreting micro- or macroadenoma) and its clinical manifestation (galactorrhoea, oligomenorrhea, infertility, reduced libido).

נורפרולק 0.075 מג טבליות Ισραήλ - Εβραϊκά - Ministry of Health

נורפרולק 0.075 מג טבליות

ferring pharmaceuticals ltd - quinagolide as hydrochloride - טבליה - quinagolide as hydrochloride 0.075 mg - quinagolide - quinagolide - second line treatment of hyperprolactinaemia (idiopathic or due to prolactin secreting micro- or macroadenoma) and its clinical manifestation (galactorrhoea, oligomenorrhea, infertility, reduced libido).

נורפרולק 0.15 מג טבליות Ισραήλ - Εβραϊκά - Ministry of Health

נורפרולק 0.15 מג טבליות

ferring pharmaceuticals ltd - quinagolide as hydrochloride - טבליה - quinagolide as hydrochloride 0.15 mg - quinagolide - quinagolide - second line treatment of hyperprolactinaemia (idiopathic or due to prolactin secreting micro- or macroadenoma) and its clinical manifestation (galactorrhoea, oligomenorrhea, infertility, reduced libido).

BODY POLISH-ג'ל גרגירים Ισραήλ - Εβραϊκά - Ministry of Health

body polish-ג'ל גרגירים

א.ל. ארמן יצור תמרוקים בעמ - שיפור מראה העור

אפודיקס קרם % 5 Ισραήλ - Εβραϊκά - Ministry of Health

אפודיקס קרם % 5

megapharm ltd - fluorouracil - קרם - fluorouracil 50 mg / 1 g - pyrimidine analogues - antineoplastic agent to treat actinic keratosis multiple and superfacial basel cell carcinoma.